Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Mar 18 2020 Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
2. Mar 10 2020 Nemaura Medical Enters Into Multiple Verbal Non-Binding Agreements for its sugarBEAT® Platform
3. Feb 25 2020 Nemaura Medical Plans Head-to-head Study with Major Glucose Monitoring System
4. Feb 11 2020 Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019